Removed TAR Requirement for Select Cold/Cough and Acetaminophen Products
May 14, 2020
The Department of Health Care Services (DHCS) continues to closely monitor the 2019 novel Coronavirus (COVID-19) situation and provide updates and guidance to Medi-Cal providers in response to concerns or questions related to the Medi-Cal fee-for-service (FFS) and Family PACT pharmacy benefit. To that end, effectively immediately, nonlegend adult acetaminophen-containing products and nonlegend cough and cold products, selected by the department, are temporarily reinstated as covered benefits of the Medi-Cal program, without requirement of an approved Treatment Authorization Request (TAR) for fee-for-service Medi-Cal beneficiaries. The full policy document is published on the COVID-19 webpage at: Pharmacy - Coverage of Acetaminophen, and Cough and Cold Medicines for Adults. This temporary change will remain in place until further notice.
Although this policy is effective, claims will not process until system changes are complete.